Abstract
Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.
Translated title of the contribution | Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture |
---|---|
Original language | Spanish |
Pages (from-to) | 380-383 |
Number of pages | 4 |
Journal | Archivos de la Sociedad Espanola de Oftalmologia |
Volume | 86 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2011 |
Keywords
- Bevacizumab
- Choroidal neovascularisation
- Choroidal rupture
- Ocular traumatism
- Pneumatic displacement
- Recombinant tissue plasminogen activator (rTPA)
- Submacular haemorrhage
ASJC Scopus subject areas
- Ophthalmology